Intrinsic Value of S&P & Nasdaq Contact Us

Virpax Pharmaceuticals, Inc. VRPX OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
33/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
+599900%

Stock Statistics — VRPX

Virpax Pharmaceuticals, Inc. (VRPX) has a market capitalization of $621.00 and trades at $0.00. The 52-week range is 0.0001-0.51.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-2,836.41.

The stock has a beta of 2.44, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0001-0.51
Volume51
Avg Volume (30D)407
Market Cap$621.00
Beta (1Y)2.44
Company
IPO Date2021-02-17
Employees2
CEOJatinder Dhaliwal
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS9282513053
CUSIP928251305
Income (Latest Year)
EBITDA$-12.08B
Operating Income$-12.08B
Net Income$-12.07B
EPS$-2,836.41
EPS Diluted$-2,836.41
Shares Outstanding$4.25M
Balance Sheet (Latest Year)
Total Assets$1.56B
Current Assets$1.56B
Cash & ST Investments$1.51B
Total Liabilities$2.47B
Net Debt$-1.51M
Total Equity$-913.76M
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message